Esperion Therapeutics
ESPR
#6949
Rank
S$0.75 B
Marketcap
S$2.95
Share price
-9.41%
Change (1 day)
81.54%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -S$37.01 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are S$0.30 Billion. In 2024 the company made an earning of S$9.57 Million, an increase over its 2023 earnings that were of -S$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$37.01 Million-486.64%
2024 S$9.57 M-104.99%
2023 -S$0.2 Billion-15.03%
2022 -S$0.23 Billion-20.61%
2021 -S$0.29 Billion84.28%
2020 -S$0.16 Billion35.75%
2019 -S$0.12 Billion-55.71%
2018 -S$0.26 Billion19.57%
2017 -S$0.22 Billion125.39%
2016 -S$95.14 Million51.43%
2015 -S$62.83 Million36.45%
2014 -S$46.05 Million43.55%
2013 -S$32.08 Million145.26%
2012 -S$13.08 Million
2002 -S$37.29 Million-7.81%
2001 -S$40.45 Million15.03%
2000 -S$35.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$12.99 B-37,241.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$6.67 B-19,161.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-S$0.65 Billion 1,754.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-S$87.46 Million 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$0.24 M-100.70%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.61 B-1,858.24%๐Ÿ‡บ๐Ÿ‡ธ USA